Skip to content
Finance Investment

Investability enters its Sixth Year with New Client Partnerships and a bigger Investor-Events Program

Investability 3 mins read

Investability enters its Sixth Year with New Client Partnerships and a bigger Investor-Events Program

Photo Courtesy of: Investability

SYDNEY, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Investability, the Sydney-headquartered investor relations consultancy founded in 2020, is entering its sixth year with new client mandates and an expanded calendar of investor events across Australia and key international markets.

Founded in 2020, Investability has grown into a trusted advisor for small-cap and growth-focused companies listed on the ASX, LSE, and TSX. The firm has supported over 70 clients in raising more than AUD $1billion in equity and completing mergers and acquisitions worth over USD $450 million.

In 2025, Investability expanded services and is scaling operations into 2026 to support a growing client base and deepen engagement with investors through curated events and strategic communications. Highlights of the year included Founder and Principal Dannika Warburton hosting a precious-metals panel and presenting to 180+ investors and 40+ CEOs at the Ignite Investment Summit in Hong Kong, co-hosting ‘Mining Rockstars’, an invite-only Sydney investor forum that drew 120+ investors and six ASX-listed miners, and the opening of a new Perth office.

“This has been a milestone year for Investability, and we’re proud of the progress we’ve made since 2020,” said Warburton. “We’ve built strong, lasting relationships with clients and investors, and we’re excited to continue expanding our reach while delivering clear, high-quality investor communications.”

As part of its sixth-year initiatives, Investability has announced a full calendar of investor events throughout 2026. The lineup includes:

  • Perth – 16 February 2026
  • Melbourne – 19 March 2026
  • Sydney – 6 May 2026
  • Adelaide – 11 September 2026
  • Sydney – 27 October 2026

In addition to live events, Investability continues to host regular investor webinars and online briefings. These formats provide listed and pre-IPO companies with flexible opportunities to connect directly with the investment community, particularly Australia’s fast-growing self-managed super fund (SMSF) investor base.

“We’re focused on creating platforms where companies can tell their stories clearly and directly to investors,” Warburton said. “Our event strategy is about building visibility and trust in a structured, measurable way.”

Investability’s event series supports its broader service offering, which includes strategic investor communications, digital marketing campaigns, roadshows, content development, and investor sentiment analysis. The company is also working on new tools to help clients track investor engagement in real time and tailor communications accordingly.

For more information about Investability or to register for upcoming events, visit: https://mailchi.mp/investability/2026eventinterest

About Investability
Investability is a boutique investor relations consultancy headquartered in Sydney, Australia. Founded in 2020, the firm provides strategic communications and investor engagement services to listed and pre-IPO companies across the ASX, LSE, and TSX. With deep expertise in capital markets and a strong investor network, Investability helps clients raise capital, build trust, and communicate their equity story effectively. The firm’s offerings include roadshows, content creation, investor events, digital marketing, capital raising support, and performance reporting.

Contact Information:
Name: Dannika Warburton
Company: Investability Partners
Email: [email protected]
Website: www.investability.com.au

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/69773582-3504-48e5-80ab-59e462b166a2


More from this category

  • Finance Investment
  • 13/01/2026
  • 13:40
Moomoo

Focused on AI, Australian investors expect 2026 to deliver

SYDNEY, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Australian investors have started the new year with an overwhelming appetite for artificial intelligence and expectations of solid returns from their increasingly global portfolios, a comprehensive new survey by stock broking firm Moomoo Australia and New Zealand reveals.The detailed survey of more than 600 Australian investors' expectations and intentions for the year complements the release of moomoo's 2026 Market Outlook today, where our local experts and global research team analyse key trends in financial markets for the year ahead.And this year, investors are committing to high-growth sectors, including AI – showing a willingness…

  • Finance Investment, Oil Mining Resources
  • 13/01/2026
  • 10:22
Jane Morgan Management

Patriot Resources reports significant silver and gold results validating Kitumba polymetallic target in Zambia

Perth, Australia – 13 January 2026: Patriot Resources Limited (ASX: PAT) has reported significant silver and gold assay results from its Phase 1 trenching program at Target B1 within the Company’s 80%-owned Kitumba 27715 Project in Zambia, further validating the prospect as a near-surface polymetallic system. The latest results add silver and gold credits to previously announced strong copper, zinc and lead geochemistry, reinforcing the scale and potential economic significance of the mineralised system. The Company said the combination of metals highlights a unique polymetallic signature and strengthens confidence in Target B1 as a priority focus for ongoing exploration. Notable…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 13/01/2026
  • 10:09
Jane Morgan Management

NeuroScientific Biopharmaceuticals (ASX:NSB) Reports Clinical Response for StemSmart(TM) Treatment in Fistulising Crohn’s Disease Under Special Access Program

13 January 2026 – Perth, Australia | NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has today announced a “Clinical Response” from patients treated with its patented StemSmart™ Mesenchymal Stem Cell (MSC) therapy under the Therapeutic Goods Administration’s (TGA) Special Access Scheme (SAS) for fistulising Crohn’s disease. Three of four patients treated in Cohort 1 of the Special Access Program demonstrated a successful “Clinical Response” following treatment with StemSmart™, with the fourth patient showing a partial response with further clinical assessment needed. A Clinical Response is defined as either closure of at least 50 per cent of fistula openings or a reduction in fistula…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.